AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 | Industry: Pharmaceuticals
| Expensive Performer
9077.5000 -105.00 (-1.14%)
NSE Nov 07, 2025 15:31 PM
Volume: 15,929
 

logo
AstraZeneca Pharma India Ltd.
edited 26 Nov 2020
9077.50
-1.14%
Serum Institute may conduct more tests to get half-dose efficacy
Serum Institute may conduct more tests to get half-dose efficacy
Moneycontrol
Preliminary results on the AstraZeneca vaccine were based on a total of 131 COVID-19 cases in a study involving 11,636 participants.
Number of MF schemes decreased from 60 to 20 in Sep 2025 qtr
Sputnik V to AstraZeneca: 'Combine your vaccine with ours to boost efficacy'
Business Today | 27 Nov 2020 9 more
More from AstraZeneca Pharma India Ltd.
Recommended
Five Interesting Stocks Today - November 7, 2025
The Baseline | 07 Nov 2025, 04:49PM
Market closes lower, NHPC's Q2 net profit grows 12% YoY
Trendlyne Marketwatch | 07 Nov 2025, 04:12PM
The banking boom: Rising profits, and a wave of investor confidence
The Baseline | 06 Nov 2025